Muscle-specific isoform of the mitochondrial ATP synthase ␥ subunit (F 1 ␥) was generated by alternative splicing, and exon 9 of the gene was found to be lacking particularly in skeletal muscle and heart tissue. Recently, we reported that alternative splicing of exon 9 was induced by low serum or acidic media in mouse myoblasts, and that this splicing required de novo protein synthesis of a negative regulatory factor (Ichida, M., Endo, H., Ikeda, U., Matsuda, C., Ueno, E., Shimada, K., and Kagawa, Y. (1998) J. Biol. Chem. 273, 8492-8501; Hayakawa, M., Endo, H., Hamamoto, T., and Kagawa, Y. (1998) Biochem. Biophys. Res. Commun. 251, 603-608). In the present report, we identified a cis-acting element on the muscle-specific alternatively spliced exon of F 1 ␥ gene by an in vivo splicing system using cultured cells and transgenic mice. We constructed a F 1 ␥ wild-type minigene, containing the full-length gene from exon 8 to exon 10, and two mutants; one mutant involved a pyrimidine-rich substitution on exon 9, whereas the other was a purine-rich substitution, abbreviated as F 1 ␥ Pudel and F 1 ␥ Pu-rich mutants, respectively. Based on an in vivo splicing assay using low serum-or acid-stimulated splicing induction system in mouse myoblasts, Pudel mutation inhibited exon inclusion, indicating that a Pu-del mutation would disrupt an exonic splicing enhancer. On the other hand, the Pu-rich mutation blocked muscle-specific exon exclusion following both inductions. Next, we produced transgenic mice bearing both mutant minigenes and analyzed their splicing patterns in tissues. Based on an analysis of F 1 ␥ Pu-del minigene transgenic mice, the purine nucleotide of this element was shown to be necessary for exon inclusion in non-muscle tissue. In contrast, analysis of F 1 ␥ Pu-rich minigene mice revealed that the F 1 ␥ Pu-rich mutant exon had been excluded from heart and skeletal muscle of these transgenic mice, despite the fact mutation of the exon inhibited muscle-specific exon exclusion in myotubes of early embryonic stage. These results suggested that the splicing regulatory mechanism underlying F 1 ␥ pre-mRNA differed between myotubes and myofibers during myogenesis and cardiogenesis.Alternative pre-mRNA splicing is a fundamental process in eukaryotes that contributes to tissue-specific and developmentally regulated patterns of gene expression at the posttranscriptional level. Recently, both cis-acting elements and transacting factors have been reported to varying degrees (1-3). Significant progress has been made in identifying the alternative splicing mechanism involved in the Drosophila sex determination pathway (4 -7).Exonic and intronic cis-acting regulatory elements for RNA splicing have been reported in a number of mammalian genes located near weak 5Ј and 3Ј splice sites, and these elements appear to be involved in the control of stage-or tissue-specific splicing events (5, 8 -13). For example, a majority of exonic splicing enhancer (ESE) 1 elements have been reported to be abundant in purine nucleotides (14,15), ...